Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

02. April 2012 15:57 ET | Quelle: Boston Therapeutics, Inc.

Boston Therapeutics Corporate Update

MANCHESTER, NH--(Marketwire - Apr 2, 2012) - Boston Therapeutics Inc. (OTCBB: BTHE), a developer of diabetes therapeutics, reviews the series of events that have led to the availability of its lead...
02. März 2012 17:13 ET | Quelle: Boston Therapeutics, Inc.

Boston Therapeutics to Be Quoted as BTHE on the OTC Bulletin Board

MANCHESTER, NH--(Marketwire - Mar 2, 2012) - Boston Therapeutics, Inc. (OTCBB: BTHE), a developer of diabetes therapeutics, is pleased to announce that it has received clearance by FINRA on...
24. Januar 2012 11:40 ET | Quelle: Boston Therapeutics, Inc.

Boston Therapeutics Announces Clinical Study Safety Results With SUGARDOWN(R) at University of Sydney

MANCHESTER, N.H., Jan. 24, 2012 (GLOBE NEWSWIRE) -- Boston Therapeutics, Inc. (BTI), a developer of diabetes therapeutics, announced today the clinical trial results in healthy volunteers performed at...